THU-382 Lead-in cohort results from a phase 2 study of a novel 8-week combination regimen of Bemnifosbuvir and Ruzasvir in patients with chronic hepatitis C virus infection
Saved in:
| Published in | Journal of hepatology Vol. 80; p. S819 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier B.V
01.06.2024
|
| Online Access | Get full text |
Cover
Loading…
| Author | Mitrut, Paul Izmailyan, Sergey Hammond, Janet Lynch, Shannan Zhou, Xiao-Jian Jucov, Alina Cernat, Roxana Majarian, Marina Iliescu, Laura Ermacicova, Elena Belanger, Bruce Horga, Arantxa Pietropaolo, Keith Florescu, Simin Conway, Brian |
|---|---|
| Author_xml | – sequence: 1 givenname: Alina surname: Jucov fullname: Jucov, Alina – sequence: 2 givenname: Brian surname: Conway fullname: Conway, Brian – sequence: 3 givenname: Laura surname: Iliescu fullname: Iliescu, Laura – sequence: 4 givenname: Paul surname: Mitrut fullname: Mitrut, Paul – sequence: 5 givenname: Simin surname: Florescu fullname: Florescu, Simin – sequence: 6 givenname: Roxana surname: Cernat fullname: Cernat, Roxana – sequence: 7 givenname: Elena surname: Ermacicova fullname: Ermacicova, Elena – sequence: 8 givenname: Shannan surname: Lynch fullname: Lynch, Shannan – sequence: 9 givenname: Marina surname: Majarian fullname: Majarian, Marina – sequence: 10 givenname: Sergey surname: Izmailyan fullname: Izmailyan, Sergey – sequence: 11 givenname: Xiao-Jian surname: Zhou fullname: Zhou, Xiao-Jian – sequence: 12 givenname: Keith surname: Pietropaolo fullname: Pietropaolo, Keith – sequence: 13 givenname: Bruce surname: Belanger fullname: Belanger, Bruce – sequence: 14 givenname: Arantxa surname: Horga fullname: Horga, Arantxa – sequence: 15 givenname: Janet surname: Hammond fullname: Hammond, Janet |
| BookMark | eNqFkM9O3DAQxi1EJRbaR0DykR4MtpN4nRNqV_yTVqrUwtly7DExbOyVneyKPlMfEgcQ11488uj3fTPzHaPDEAMgdMroOaNMXPwpjySSL-UZr79TzpslkQdowQSlhIqaHaLFJ3KEjnN-opRWtK0X6N_97QOpJMdr0Jb4gE3sYxpxgjxtxoxdigPWeNvrDJjjPE72BUdXWiHuYIMl2QM8F9XQ-aBHH0ORPvoBwkz9hCF4F3M37XzCOlj8e_qr8_wpo7aFh1CG7P3YY9OnGLzBPcz90We8wgWcckEdmNn6K_ri9CbDt496gh6ur-5Xt2T96-Zu9WNNDKNcEttK0bWOS-1A101FGyoaJxvbuKoWXcMoNcLYdik66JZVy62thYWayQpay6E6Qc27r0kx5wRObZMfdHpRjKo5cvUWuZrzVLxWb5ErWXSX7zooy-08JJVNudCA9alcoGz0_3F4BRIDjNU |
| ContentType | Journal Article |
| Copyright | 2024 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2024 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION |
| DOI | 10.1016/S0168-8278(24)02257-8 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1600-0641 |
| EndPage | S819 |
| ExternalDocumentID | 10_1016_S0168_8278_24_02257_8 S0168827824022578 |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29K 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAXUO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 D-I DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HX~ HZ~ IHE J1W KOM LZ1 M27 M41 MJL MO0 N9A O-L O9- OAUVE OC. ON0 OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K TEORI UV1 WUQ X7M YOC Z5R ZGI ~G- AAXKI AAYXX ADVLN AFJKZ CITATION |
| ID | FETCH-LOGICAL-c1028-d986b9f28afea45305065f85d5f346b5100c6cd976beb7392dd46de4183e9d2e3 |
| IEDL.DBID | .~1 |
| ISSN | 0168-8278 |
| IngestDate | Thu Sep 26 21:34:11 EDT 2024 Wed Jun 26 17:52:16 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c1028-d986b9f28afea45305065f85d5f346b5100c6cd976beb7392dd46de4183e9d2e3 |
| ParticipantIDs | crossref_primary_10_1016_S0168_8278_24_02257_8 elsevier_sciencedirect_doi_10_1016_S0168_8278_24_02257_8 |
| PublicationCentury | 2000 |
| PublicationDate | June 2024 2024-06-00 |
| PublicationDateYYYYMMDD | 2024-06-01 |
| PublicationDate_xml | – month: 06 year: 2024 text: June 2024 |
| PublicationDecade | 2020 |
| PublicationTitle | Journal of hepatology |
| PublicationYear | 2024 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| SSID | ssj0003094 |
| Score | 2.489325 |
| SourceID | crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | S819 |
| Title | THU-382 Lead-in cohort results from a phase 2 study of a novel 8-week combination regimen of Bemnifosbuvir and Ruzasvir in patients with chronic hepatitis C virus infection |
| URI | https://dx.doi.org/10.1016/S0168-8278(24)02257-8 |
| Volume | 80 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwELYQSKiXqpRWhRY0Bw7tweyu42SdI6xAWyo4tKzELYrjsYjKelebhEo99Il4SGaSrACp6qHHjDxONDOa-RzPjxBHmlBGotRYjvjWXY80SmOcl8rlo7GNGYVw7fDlVTKd6Yub-GZDTNa1MJxW2fv-zqe33rqnDHppDpZlOfhBYIXgIUU4OgKx4XEFO1kY2fTxn6c0j2iY9v29jeTVT1U83Q4t8bPSX9pNpPl7fHoWc87fiNc9WIST7nt2xAaGt2L7sr8O3xUP19OZjIwCHpQpywA87nZVAx2hm7u6Aq4dgRyWtxSqQEHbShYWnkhhcY93YOQvxJ_ENafzcasi4EENcwy86hTnofSLyjb35Qry4OB78zuv-IFe1TdkrYD_5ELR9diFW2R6XVYwAVrYVLDO9grvxOz87Hoylf34BVkw6pAuNYlNvTK5x1zH5BgIrngTu9hHOrEk6mGRFI7wjEU7JpzlnE4canISmDqF0XuxGRYBPwhw1qfEPI5wqLUfWlOkBTkLbkWjNCLuieO10LNl12Uje5Z-lpiMtZQpnbVaysyeMGvVZC_MJaNI8G_W_f9n_SheKcI0XabYJ7FZrxo8IExS28PW6A7F1snXb9OrRwY23Bo |
| link.rule.ids | 315,783,787,4510,24129,27937,27938,45598,45692 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkaAXVF6ihcIcOMDB3V3HyTpHWFEt0O0BdqXerDgeqxHd7GqTtFIP_CJ-JDNJVi0S4sAxI48TeSYzn-15CPFWE8pIlBrLEd-665FGaYwPUvlsNHYxoxDOHZ6dJdOF_nIen--IyTYXhsMqe9vf2fTWWveUQb-ag3VRDL4TWCF4SB6OtkCsePfEfc3lxkmpj3_exnlEw7Qv8G0kD79N4-mmaInvlH7fziLN3x3UHadzsi8e9WgRPnQf9FjsYPlEPJj19-FPxa_5dCEjo4A7ZcqiBO53u6mB9tDNZV0BJ49ABusL8lWgoK0lC6tApHJ1hZdg5DXiD-Ja0ga5lRFwp4YlljzqIy7LIqwq11wVG8hKD9-am6ziB3pVX5G1Aj7KhbwrsgsXyPS6qGACNLCpYBvuVT4Ti5NP88lU9v0XZM6wQ_rUJC4NymQBMx2TZSC8Ekzs4xDpxNHfPMyT3BOgcejGBLS814lHTVYCU68wei52y1WJLwR4F1JiHkc41DoMncnTnKwF16JRGhEPxPF20e26K7Nh78SfJcaylKzStpWSNQfCbEVj_9AXS67g36yH_8_6Rjyczmen9vTz2deXYk8RwOnCxl6J3XrT4BEBlNq9bhXwN2B73bw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=THU-382+Lead-in+cohort+results+from+a+phase+2+study+of+a+novel+8-week+combination+regimen+of+Bemnifosbuvir+and+Ruzasvir+in+patients+with+chronic+hepatitis+C+virus+infection&rft.jtitle=Journal+of+hepatology&rft.au=Jucov%2C+Alina&rft.au=Conway%2C+Brian&rft.au=Iliescu%2C+Laura&rft.au=Mitrut%2C+Paul&rft.date=2024-06-01&rft.issn=0168-8278&rft.volume=80&rft.spage=S819&rft_id=info:doi/10.1016%2FS0168-8278%2824%2902257-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_S0168_8278_24_02257_8 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-8278&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-8278&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-8278&client=summon |